Intra-abdominal pressure alterations after large pancreatic pseudocyst transcutaneous drainage by Papavramidis, Theodossis S et al.
BioMed  Central
Page 1 of 5
(page number not for citation purposes)
BMC Gastroenterology
Open Access Research article
Intra-abdominal pressure alterations after large pancreatic 
pseudocyst transcutaneous drainage
Theodossis S Papavramidis*, Vassilis Duros, Antonis Michalopoulos, 
Vassilis N Papadopoulos, Daniel Paramythiotis and Nick Harlaftis
Address: 1st Propedeutic Department of Surgery, AHEPA University Hospital, Aristotle's University of Thessaloniki, Macedonia, Greece
Email: Theodossis S Papavramidis* - papavramidis@hotmail.com; Vassilis Duros - vfduros@yahoo.gr; 
Antonis Michalopoulos - amichal@med.auth.gr; Vassilis N Papadopoulos - bnpap2003@yahoo.com; 
Daniel Paramythiotis - danosprx@med.auth.gr; Nick Harlaftis - papavramidou@hotmail.com
* Corresponding author    
Abstract
Background: Acute pancreatitis leads to abdominal hypertension and compartment syndrome.
Weeks after the episodes pancreatic fluids sometimes organize to pseudocysts, fluid collections by
or in the gland.
Aims of the present study were to evaluate the intra-abdominal pressure (IAP) induced by large
pancreatic pseudocysts and to examine the effect of their transcutaneous drainage on IAP.
Methods: Twenty seven patients with a pancreatic pseudocyst were included. Nine patients with
pseudocysts greater than 1l (group A) had CT drainage and eighteen (volume less than 1l) were the
control group. The measurements of group A were taken 6 hours before and every morning after
the drainage, while for group B, two measurements were performed, one at the day of the initial
CT and one 7 days after. Abdominal compliance (Cabd) was calculated. Data were analyzed using
student's t-test.
Results: Baseline IAP for group A was 9.3 mmHg (S.D. 1.7 mmHg), while the first post-drainage
day (PDD) IAP was 5.1 mmHg (S.D. 0.7 mmHg). The second PDD IAP was 5.6 mmHg (S.D. 0.8
mmHg), the third 6.4 mmH (S.D. 1.2 mmHg)g, the fourth 6.9 mmHg (S.D. 1.6 mmHg), the fifth 7.9
mmHg (S.D. 1.5 mmHg), the sixth 8.2 mmHg (S.D. 1.4 mmHg), and the seventh 8.2 mmHg (S.D.
1.5 mmHg). Group B had baseline IAP 8.0 mmHg (S.D. 1.2 mmHg) and final 8.2 mmHg (S.D. 1.4
mmHg). Cabd after drainage was 185.6 ml/mmHg (SD 47.5 ml/mmHg).
IAP values were reduced between the baseline and all the post-drainage measurements in group A.
IAPs seem to stabilize after the 5th post-drainage day. Baseline IAP was higher in group A than in
group B, while the two values, at day 7, were equivalent.
Conclusion: The drainage of large pancreatic pseudocyst reduces IAP. Moreover, the IAP seems
to rise shortly after the drainage again, but in a way that it remains inferior to the initial value. More
chronic changes to the IAP are related to abdominal cavity's properties and have to be further
studied.
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Background
Intra-abdominal pressure (IAP) is the pressure main-
tained in the abdominal cavity. It can be measured using
various techniques, but the most used and the easiest to
apply is the transvesical [1-3]. Under normal conditions –
no pathologies – and with the patient calm and at supine
position, IAP ranges from 1 to 6.5 mmHg [2-4].
It is well known that acute pancreatitis is one of the most
frequent reasons leading to abdominal hypertension
(IAH) and abdominal compartment syndrome (ACS) [5-
8]. The management of IAH and ACS has many aspects [9-
12] concerning the decompression of the abdomen and
the amelioration of the condition of the patient. After the
acute episode of pancreatitis, free pancreatic fluids some-
times organize weeks after the episodes, to pseudocysts.
Pancreatic pseudocysts are pancreatic fluid collections by
or in the gland. The size of the pseudocysts varies from
small (<2 cm), to medium (2–6 cm), and large (>6 cm),
mirroring the amount of fluid contained in the cyst.
The present study was based on the hypothesis that large
pancreatic pseudocysts tend to alter IAP. Aims of the
present study were to evaluate alterations of IAP due to
large pancreatic pseudocysts and to examine the effect of
transcutaneous pseudocyst drainage on IAP.
Methods
The present prospective study lasted from 1 Sep 2006 to
31 Dec 2007. Twenty seven patients with a pancreatic
pseudocyst, treated in the 1st Propedeutic Department of
Surgery of AHEPA University hospital in Thessaloniki
were included. The study was approved by the ethics com-
mittee of AHEPA University Hospital and written
informed consent was obtained by all patients.
Two groups were formed. All patients that fulfilled the
below-mentioned criteria entered group A. The criteria
were: (i) presence of large pseudocyst (volume of pseudo-
cyst calculated greater than 1l), (ii) no signs of chronic
pancreatitis (e.g pain or CT findings), (iii) no signs of
acute pancreatitis (e.g pain, amylasemia, CT findings)
present for the last 2 months. In group A 9 patients (6
males and 3 females) were included. On the other hand,
group B included the remaining 18 patients (10 males, 8
females). The mean age of the patients was 72.2 years
(range 64 to 78 years). The Body Mass Index averaged
27.2 kg/m2 (S.D. 3.2 kg/m2) for group A and 26.8 kg/m2
(S.D. 2.7 kg/m2) for group B. The mean volume of the ini-
tially drained pseudocyst fluid was 2313 ml (ranging from
1200 to 3200 ml, S.D 825 ml). The mean volume of the
non-drained pseudocysts (Group B) was calculated as 353
ml (ranging from 240 to 540 ml, S.D. 97 ml). The demo-
graphic data for both groups is showed in table 1.
In order to measure IAP in group A, a Foley catheter was
inserted into the urinary bladder using a standard sterile
technique 6 hours before the Computed Tomography
(CT) guided transcutaneous drainage of the pseudocyst.
The bladder was filled with 50 mL of sterile saline using a
closed-system technique [13]. The hydrostatic pressure in
the bladder was obtained by connecting the catheter to a
pressure transducer through sterile tubing [14]. Pressure
measurements were made in cmH2O and then converted
into mmHg. The zero reference point for the measure-
ments was set at the symphyse pubis. The median value of
three separate measurements was recorded with the
patient relaxed in the supine position. The measurements
were taken 6 hours before the drainage and at 8 o'clock
every morning, for the 7 days following the drainage.
Concerning group B, two measurements were performed,
one at the day of the initial CT and one 7 days after. On
the 7th day a control CT was performed in order to evalu-
ate the condition of the abdominal cavity. In group A, no
remaining pseudocyst was detected.
Abdominal wall compliance (Cabd) was calculated using
the formula: Cabd = ΔIntra-abdominal Volume (ΔIAV)/
ΔIAP [15]. The above formula was transformed to Cabd =
-Volume of fluid drained by the pseudocyst/Post drainage
IAP – Baseline IAP.
Data was analyzed using standard statistical methods.
Descriptive statistics including means, ranges, and stand-
ard deviations were used to describe the IAP measurement
for each subject. Comparison between participants were
made using a paired Student's t-test after performing one
sample Kolmogorov-Smirnof test which proved that dis-
tribution was normal in all three time instances. A p value
of 0.05 was considered significant for all tests.
Results
Concerning group A, the mean baseline IAP (D0) was 9.3
mmHg (range, 6.6–12.5 mmHg, S.D. 1.7 mmHg). On the
same day (D0), group B presented IAP equal to 8.0 mmHg
(range, 6.6–9.2 mmHg, S.D 1.2 mmHg) [p = 0.001].
Table 1: Patients Demographics
Group A Group B p
Age (y) 71.9 72.5 ns
Gender
(Male/Female) 6/3 10/8
Mean BMI (kg/m2) 27.2 26.8 ns
Mean Fluid Volume (ml) 2313 353 0.001
Baseline IAP (mmHg) 9.3 8.0 0.001BMC Gastroenterology 2009, 9:42 http://www.biomedcentral.com/1471-230X/9/42
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The final IAP (D7) for group A was 8.2 mmHg (range 6.6–
11.4 mmHg, S.D 1.5 mmHg), while for group B it was 8.2
mmHg (range 6.6–8.8 mmHg, S.D 1.4 mmHg) [p = ns].
Mean Cabd, for group A, was 185.6 ml/mmHg (range
from 120.6 to 242.2 ml/mmHg, SD 47.5 ml/mmHg).
Finally, the evolution of the IAPs in group A, after the
drainage is displayed in Figure 1.
Concerning group A, paired student's T-test showed statis-
tically significant IAP differences between the baseline
and all the post-drainage values. Furthermore, it is impor-
tant to notice that IAPs seem to stabilize after the 5th post-
drainage day since no statistical difference appears
between 5th, 6th an 7th PDD.
Discussion
In the present study the baseline IAP values were signifi-
cantly elevated in group A in comparison with group B
patients. The fact that pancreatic pseudocysts are posi-
tioned retroperitoneally doesn't alter the fact that they
occupy abdominal space and therefore increase IAP. This
seems very logical since the volume of the fluid contained
in the large pseudocysts of group A occupies a greater per-
centage of the total abdominal volume than that of the
small pseudocysts of group B patients. These chronically
increased IAPs are below pressures inducing IAH (≥ 12
mmHg), as defined by world society of the abdominal
compartment syndrome (WSACS) [16-18]. By definition,
those IAPs cause no clinically appreciable alterations, but
special attention has to be paid when additional patholo-
gies are present. In order to prevent the accumulation of
multiple pathologies and the off-balancing of IAP towards
IAH and ACS, we believe that large pancreatic pseudocyst
drainage has to be done as early as possible.
The immediate post-drainage IAP values on the 1st day
were statistically significantly lower in comparison to the
pre-drainage ones. This appears to be easily explained
since the decompression of the abdominal cavity was
achieved by removing the fluid of the pseudocyst. Simple
laws of physics suffice to describe the alteration of IAP
immediately after the drainage. The Pascal principle
implies that pressure equals force divided by the surface.
Given the fact that the surface remains stable, after the
drainage, the force is the sole factor influencing IAP. The
force implied is proportional to the volume of the intra-
abdominal structures. We can easily understand that
when the intra-abdominal volume decreases then the
force is reduced and therefore the IAP decreases. As a con-
clusion, the immediate decrease of the IAP is due to phys-
ical characteristics of the abdominal cavity.
IAPs observed during the first five days after the drainage
were statistically lower than these observed in group B and
on days 6 and 7 of group A patients. Furthermore, there is
a gradual increase of the IAP starting on day 1 and reach-
ing a plateau on day 5. This gradual increase of the IAP
seems to have a multi-variant component, since IAP is
IAP variation before and after CT-guided pseudocyst drainage Figure 1
IAP variation before and after CT-guided pseudocyst drainage.BMC Gastroenterology 2009, 9:42 http://www.biomedcentral.com/1471-230X/9/42
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maintained by several factors such as: (i) characteristics of
the abdominal wall – anterior and posterior-, (ii) proper-
ties of the diaphragm, (iii) volume of the organs in the
abdomen, (iv) intra-thoracic pressure, (v) pain and (vi)
muscle contraction. The above mentioned factors seem to
adapt gradually to the new conditions leading to a re-esca-
lation to the new IAP that stabilizes after the 5th post-
drainage day.
For the present study 50 ml of saline water were instilled
ml into the bladder in order to perform the IAP measure-
ment. However, WSACS advocated instilling a maximal
amount of 25 ml into the bladder [16]. Unfortunately the
study protocol had already started when the guidelines
were published. Despite the fact that recent data showed
that instilling 50 ml may increase intrinsic bladder pres-
sure [19-22], we believe that the results of this study were
not affected, because the aim was not to simply measure
the IAP, but to evaluate differences of baseline and post-
drainage IAP.
The clinical significance of the elevated IAP is not clear.
Elevated IAP due to pseudocysts probably has for the
moment only pure scientific value. However, the fact that
draining this pseudocyst reduces IAP may help in con-
fronting with problems induced by the pseudocyst even in
IAP value below IAH when multiple pathologies are accu-
mulated.
Conclusion
The present study demonstrates that the drainage of large
pancreatic pseudocyst reduces the IAP both in an acute
and in a chronic basis. Moreover, the IAP seems to rise
shortly after the drainage again, but it remains at all time
inferior to the initial value. More chronic changes to the
IAP are related to abdominal cavity's properties which
need more time to alter, and have to be further studied.
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